
### [MONDO:0018329](http://purl.obolibrary.org/obo/MONDO_0018329)
**Label:** persistent combined dystonia

**Subclasses:** [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0016812](http://purl.obolibrary.org/obo/MONDO_0016812) (Dopa-responsive dystonia), [MONDO:0011551](http://purl.obolibrary.org/obo/MONDO_0011551) (autosomal recessive dopa-responsive dystonia), [MONDO:0000903](http://purl.obolibrary.org/obo/MONDO_0000903) (myoclonus-dystonia syndrome), [MONDO:0008044](http://purl.obolibrary.org/obo/MONDO_0008044) (myoclonic dystonia 11), [MONDO:0018266](http://purl.obolibrary.org/obo/MONDO_0018266) (ataxia-telangiectasia variant), 

**Corr. equiv. classes:** [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [Orphanet:370109](http://www.orpha.net/ORDO/Orphanet_370109), [Orphanet:255](http://www.orpha.net/ORDO/Orphanet_255), [OMIM:208910](http://purl.obolibrary.org/obo/OMIM_208910), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), [Orphanet:36899](http://www.orpha.net/ORDO/Orphanet_36899), [OMIM:159900](http://purl.obolibrary.org/obo/OMIM_159900), [Orphanet:101150](http://www.orpha.net/ORDO/Orphanet_101150), [OMIM:605407](http://purl.obolibrary.org/obo/OMIM_605407), [OMIM:616398](http://purl.obolibrary.org/obo/OMIM_616398), 

**Class expressions from DL-Learner:**

- [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 65.00%
- [HP:0004313](http://purl.obolibrary.org/obo/HP_0004313) (Decreased antibody level in blood) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0000777](http://purl.obolibrary.org/obo/HP_0000777) (Abnormality of the thymus) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 65.00%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0010701](http://purl.obolibrary.org/obo/HP_0010701) (Abnormal immunoglobulin level) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 65.00%
- [HP:0010701](http://purl.obolibrary.org/obo/HP_0010701) (Abnormal immunoglobulin level) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0010701](http://purl.obolibrary.org/obo/HP_0010701) (Abnormal immunoglobulin level) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0010701](http://purl.obolibrary.org/obo/HP_0010701) (Abnormal immunoglobulin level) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0005372](http://purl.obolibrary.org/obo/HP_0005372) (Abnormality of B cell physiology) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 65.00%
- [HP:0005372](http://purl.obolibrary.org/obo/HP_0005372) (Abnormality of B cell physiology) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0005372](http://purl.obolibrary.org/obo/HP_0005372) (Abnormality of B cell physiology) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%
- [HP:0005372](http://purl.obolibrary.org/obo/HP_0005372) (Abnormality of B cell physiology) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 65.00%


